Itau Unibanco Holding S.A. Sarepta Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $10,766 - $15,565	95 New	95 $15,000
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $1,750 - $3,243	-26 Reduced 13.33%	169 $16,000
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $3,936 - $5,816	-37 Reduced 15.95%	195 $22,000
Q4 2022 Feb 09, 2023	SELL	$100.86 - $132.13 $3,227 - $4,228	-32 Reduced 12.12%	232 $30,000
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $1,191 - $1,680	-19 Reduced 6.71%	264 $20,000
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $7,109 - $9,146	92 Added 48.17%	283 $26,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $329 - $462	5 Added 2.69%	191 $18,000
Q2 2021 Aug 17, 2021	BUY	$69.38 - $86.75 $12,904 - $16,135	186 New	186 $14,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.